Latest / The Well-Built Life / Exploring Social Anxiety Disorder
Transcript
- 0:00Speaker 1: Hey everyone, welcome back to the well-built life. I am
- 0:03Speaker 1: Rachel Caldwell alongside Thomas Bennett, and we are so glad
- 0:07Speaker 1: you are tuning in. We are here to cut through
- 0:09Speaker 1: the noise, skip the intense jargon and extreme rules and
- 0:13Speaker 1: share simple practical habits that help you feel stronger, healthier,
- 0:18Speaker 1: and more balanced every single day. Grab a drink, get
- 0:21Speaker 1: comfortable and let's dive in. Welcome back to the well-built
- 0:25Speaker 1: life today. We are diving into the fascinating world of
- 0:29Speaker 1: social anxiety disorder, or SAD. Let's start with the roots
- 0:33Speaker 1: of this condition. Have you been looking into how social
- 0:37Speaker 1: anxiety was first recognized and understood in the early 20th century, Thomas?
- 0:42Speaker 2: Yes, Rachel. It's interesting to trace the journey back to
- 0:45Speaker 2: the 1930s and 1940s. Early researchers started to distinguish SAD
- 0:47Speaker 2: as a distinct condition, though it was still a nascent field.
- 0:56Speaker 2: The work of Sigmund Freud, even though his theories are
- 0:59Speaker 2: now criticized, laid important groundwork. He wrote about anxiety and
- 1:04Speaker 2: its connection to social interactions, which gave us a starting point.
- 1:08Speaker 1: Right. And that's the crucial nuance here. Freud's early writings
- 1:13Speaker 1: hinted at the social context of anxiety, though his theories
- 1:16Speaker 1: on the unconscious mind and neuroticism are complex. Early researchers
- 1:21Speaker 1: in the 1930s and 1940s began to focus more directly
- 1:27Speaker 1: on the specific symptoms of social anxiety. For instance, they
- 1:31Speaker 1: noted individuals who experienced intense fears in social situations that
- 1:36Speaker 1: didn't align with the actual risks.
- 1:38Speaker 2: Exactly, which brings up an interesting contradiction. These initial studies
- 1:43Speaker 2: highlighted the discrepancy between the subjective experience of high levels
- 1:47Speaker 2: of anxiety and the actual situational outcomes. It's akin to
- 1:52Speaker 2: a speaker whose heart races before a presentation but performs
- 1:56Speaker 2: just fine during it. This disconnect was crucial for understanding
- 2:00Speaker 2: the condition's mechanisms.
- 2:02Speaker 1: Yes, exactly. The 1980s saw the DSM III introduce SAD
- 2:08Speaker 1: as a formal diagnosis, which brought more systematic categorization to
- 2:13Speaker 1: the field. Over the next few decades, research delved deeper
- 2:18Speaker 1: into the neurobiological aspects of SAD. The diagnosis of SAD
- 2:22Speaker 1: now depends on several key criteria, ensuring a more nuanced
- 2:26Speaker 1: and accurate identification.
- 2:27Speaker 2: True, and the neurobiological mechanisms have been fascinating. Take the
- 2:32Speaker 2: amygdala for example. It's crucial for the fear response, and
- 2:36Speaker 2: SAD studies have shown heightened activity in this brain region.
- 2:39Speaker 2: The insula also plays a role by misinterpreting normal bodily
- 2:43Speaker 2: sensations as threatenings. These findings highlight how the brain's wiring
- 2:48Speaker 2: can contribute to social anxiety.
- 2:50Speaker 1: Right. And the sympathetic nervous system hyperarousal is another big player.
- 2:56Speaker 1: It's like the body's fight-or-flight response is on overdrive, leading
- 3:00Speaker 1: to all those physical symptoms. This hyperarousal can be profoundly
- 3:04Speaker 1: disruptive to daily life, affecting everything from job performance to
- 3:09Speaker 1: social interactions.
- 3:10Speaker 2: Indeed. And it's important to recognize that SAD isn't just
- 3:14Speaker 2: about those biological mechanisms. Environmental factors like childhood trauma and
- 3:19Speaker 2: parental influence can significantly alter a person's risk. This nature
- 3:24Speaker 2: versus nurture debate continues to be a critical angle in
- 3:27Speaker 2: the research.
- 3:28Speaker 1: Absolutely. The median age of onset is around 13, often
- 3:33Speaker 1: with symptoms starting even earlier. This early emergence highlights the
- 3:37Speaker 1: importance of early intervention and support. But there are still
- 3:40Speaker 1: many questions out there. Thomas, for instance, how do we
- 3:45Speaker 1: balance genetic predispositions with environmental influences in the development of SAD?
- 3:50Speaker 2: That's a very good point, Rachel. And moving forward, integrating
- 3:55Speaker 2: new technologies like neurofeedback and virtual reality therapy could provide
- 3:59Speaker 2: innovative solutions. The future research might focus on more personalized
- 4:04Speaker 2: treatment approaches that address both the biological and psychological aspects
- 4:08Speaker 2: of the disorder.
- 4:09Speaker 1: Exactly. And with ongoing advancements, we might see more effective
- 4:13Speaker 1: long-term management strategies that don't rely solely on pharmacological treatments.
- 4:19Speaker 1: Thanks for diving into this complex topic with me today, Thomas.
- 4:22Speaker 1: It really helps to understand the multifaceted nature of social
- 4:25Speaker 1: anxiety disorder. So, let's dive into the nuts and bolts
- 4:29Speaker 1: of SADD. When it comes to the amygdala, it's like
- 4:32Speaker 1: the brain's early warning system. It's hyperactive and folks with SAD,
- 4:36Speaker 1: constantly on alert, ready to fire off those fight-or-flight responses.
- 4:41Speaker 2: Right.
- 4:42Speaker 1: And that's the crucial nuance here. It's not just about
- 4:45Speaker 1: the amygdala being overly sensitive, but also about how it
- 4:49Speaker 1: interacts with other parts of the brain.
- 4:51Speaker 2: Exactly. Which brings up an interesting contradiction. The amygdala is
- 4:56Speaker 2: so sensitive that it basically creates this constant state of alertness,
- 5:00Speaker 2: making the individual feel like they are always under threat,
- 5:04Speaker 2: even when to real danger. This is where the physiological
- 5:07Speaker 2: and psychological responses intersect. For example, a person might start
- 5:12Speaker 2: to sweat or their heart might race, not because they
- 5:16Speaker 2: are actually in a threatening situation, but because their amygdala
- 5:20Speaker 2: is predicting one.
- 5:21Speaker 1: That's wild when you look at the raw numbers. Studies
- 5:24Speaker 1: show that amygdala activity is significantly higher in people with
- 5:27Speaker 1: SAD during social interactions. which can make even the most
- 5:31Speaker 1: mundane social occasions feel like a nightmare. But how does
- 5:34Speaker 1: this heightened amygdala activity lead to the sympathetic nervous system
- 5:38Speaker 1: going into overdrive?
- 5:39Speaker 2: Well, the sympathetic nervous system is like the body's emergency
- 5:43Speaker 2: response team. When the amygdala rings the alarm, the sympathetic
- 5:47Speaker 2: nervous system kicks into gear, pumping out stress hormones like
- 5:51Speaker 2: adrenaline and cortisol. This is the physical side of the
- 5:55Speaker 2: equation racing heart, sweaty palms, and shockiness. It's a bit
- 5:59Speaker 2: like the body deciding it needs to fight or run away,
- 6:03Speaker 2: even if it's just a conversation over a coffee.
- 6:05Speaker 1: And let's not forget the prefrontal cortex. This area of
- 6:10Speaker 1: the brain is supposed to be the logical, executive function part, right?
- 6:14Speaker 1: In SAD, it's like the brakes are malfunctioning. The ventromedial
- 6:18Speaker 1: prefrontal cortex, specifically, can misinterpret even simple social interactions as threats,
- 6:25Speaker 1: leading to excessive anxiety. It's like the brain's worrywart mode
- 6:29Speaker 1: is always in overdrive, making it hard to think clearly
- 6:34Speaker 1: or have a normal, relaxed interaction.
- 6:36Speaker 2: That's so true, and it's a classic case of the
- 6:39Speaker 2: mind-body connection. The prefrontal cortex dysregulation means that the amygdala's
- 6:44Speaker 2: overactive state is mirrored in the body. So, even as
- 6:48Speaker 2: the brain is in high alert, the body follows suit,
- 6:51Speaker 2: amplifying the anxiety response. It's like a feedback loop. where
- 6:56Speaker 2: the body's physiological reactions reinforce the brain's irrational fears.
- 7:00Speaker 1: And it's not just a one-way street. These physiological responses
- 7:05Speaker 1: can in turn feed back into the amygdala, making it
- 7:08Speaker 1: even more vigilant. It's a vicious cycle that's hard to break,
- 7:12Speaker 1: but knowing this, it opens up the possibility for new treatments.
- 7:16Speaker 1: For instance, neurofeedback or virtual reality therapy could help train
- 7:20Speaker 1: the brain to calm the amygdala and regulate the sympathetic
- 7:24Speaker 1: nervous system.
- 7:25Speaker 2: Exactly. It's not just about treating the symptoms but understanding
- 7:29Speaker 2: the mechanisms. By addressing these underlying physiological responses, we might
- 7:34Speaker 2: be able to provide more personalized and effective treatments. The
- 7:37Speaker 2: future looks promising with these kinds of innovative approaches.
- 7:40Speaker 1: So, let's talk about the roles of medical professionals, especially
- 7:44Speaker 1: psychiatrists and psychologists, in managing SAD. They are the gatekeepers, right?
- 7:49Speaker 1: They play a crucial role in diagnosing and treating the disorder.
- 7:53Speaker 2: Absolutely. Their judgment is critical. They not only diagnose but
- 7:58Speaker 2: also educate their patients about the condition, making sure they
- 8:02Speaker 2: understand the psychological and physiological impacts. But the challenge lies
- 8:07Speaker 2: in the diagnostic criteria, which can be subjective. Right.
- 8:11Speaker 1: Sometimes the line between a mild anxiety and a full-blown
- 8:14Speaker 1: sad can be blurry. That's why ongoing education and awareness
- 8:18Speaker 1: among medical professionals are vital. What about the impact on patients?
- 8:23Speaker 1: How do they experience this treatment journey?
- 8:25Speaker 2: Patients often feel a mix of relief and anxiety. Relief
- 8:29Speaker 2: when they finally have a diagnosis, but anxiety about the
- 8:33Speaker 2: prescribed treatment, be it medication or therapy. It's a delicate balance.
- 8:38Speaker 2: Some might need a combination of both, which can be overwhelming.
- 8:41Speaker 1: True. And the journey doesn't end with diagnosis. Managing SAD
- 8:47Speaker 1: requires ongoing support and adjustments. That's where researchers come in.
- 8:52Speaker 1: What kind of insights can they provide?
- 8:55Speaker 2: Researchers are continuously exploring the neurobiological underpinnings of SAD. For example,
- 9:02Speaker 2: studies on the amygdala and its hypersensitivity can offer new
- 9:06Speaker 2: therapeutic angles. But Therese also room for alternative therapies, like meditation.
- 9:13Speaker 2: which some studies suggest can reduce sad symptoms.
- 9:16Speaker 1: Exactly. It's a multifaceted approach. Now, let's look at pharmaceutical companies.
- 9:22Speaker 1: They have significant influence, don't they? Their focus is often
- 9:26Speaker 1: on faster relief, even if it means pushing the envelope
- 9:30Speaker 1: a bit.
- 9:30Speaker 2: Indeed. They drive the market for new drugs, sometimes at
- 9:34Speaker 2: the expense of long-term effects, while this can speed up
- 9:38Speaker 2: access to newer treatments. It's important to balance that with
- 9:41Speaker 2: safety and efficacy.
- 9:43Speaker 1: Yes, the regulatory landscape is complex. It's a tightrope walk.
- 9:48Speaker 1: On the other hand, therapy providers are key. Offering personalized
- 9:53Speaker 1: and holistic approaches, cognitive behavioral therapy, CBT, and exposure therapy
- 9:59Speaker 1: are evidence-based. but they require a lot of dedication from
- 10:03Speaker 1: the patient.
- 10:03Speaker 2: Absolutely. CBT is like retraining the brain, but it takes
- 10:08Speaker 2: time and effort. The success of these therapies hinges on
- 10:12Speaker 2: the patient's commitment. However, some forms of therapy, like exposure therapy,
- 10:18Speaker 2: can be incredibly effective, even more than medications in some cases.
- 10:22Speaker 1: Speaking of commitment, it's a two-way street. Both the patient
- 10:27Speaker 1: and the provider need to invest in this process. It's
- 10:30Speaker 1: not just about the treatment, but also about building resilience
- 10:34Speaker 1: and coping mechanisms that last beyond treatment.
- 10:37Speaker 2: That's the beauty of these multidisciplinary approaches. They address the
- 10:41Speaker 2: condition from all angles. But it's a journey that requires
- 10:44Speaker 2: patience and understanding from everyone involved.
- 10:47Speaker 1: Agreed. It's a holistic approach that recognizes the complexity of
- 10:51Speaker 1: SAD and the diverse roles of all stakeholders. From medical
- 10:55Speaker 1: professionals to pharmaceuticals, research, and therapy providers, every piece of
- 11:00Speaker 1: the puzzle is crucial. The nature versus nurture argument is
- 11:04Speaker 1: a classic one. Delving into whether your genetic makeup or
- 11:07Speaker 1: your environment plays a more significant role in developing social
- 11:11Speaker 1: anxiety disorder. SAD. Let's dive into some subclinical phenotypes and
- 11:16Speaker 1: the comparative effectiveness of different therapeutic approaches. Thomas, what do
- 11:21Speaker 1: you think about the genetic underpinnings of SAD?
- 11:24Speaker 2: Right, and that's the crucial nuance here. To raise a
- 11:27Speaker 2: lot of research pointing to genetic factors, but it's also
- 11:31Speaker 2: important to consider environmental influences. For instance … A study
- 11:35Speaker 2: by the National Institute of Mental Health found that children
- 11:38Speaker 2: with a family history of SAD are twice as likely
- 11:41Speaker 2: to develop the disorder themselves. But, on the flip side,
- 11:45Speaker 2: those with no family history can still develop it due
- 11:49Speaker 2: to environmental triggers like bullying or traumatic experiences. Exactly.
- 11:55Speaker 1: Which brings up an interesting contradiction. It's not as simple
- 11:58Speaker 1: as nature or nurture. What about someone who has a
- 12:02Speaker 1: genetic predisposition to anxiety? but grows up in a nurturing environment,
- 12:07Speaker 1: never facing significant stressors, would they still develop SAD?
- 12:11Speaker 2: That's a great point. The interplay between genetics and environment
- 12:16Speaker 2: is complex. Take the concept of epigenetics. It shows how
- 12:20Speaker 2: environmental factors can physically alter gene expression without changing the
- 12:24Speaker 2: genetic code itself. So, in a nurturing environment, even with
- 12:29Speaker 2: a genetic predisposition, the likelihood of developing SAD might be
- 12:33Speaker 2: significantly reduced.
- 12:34Speaker 1: Right. And this brings us to the subclinical phenotypes. Many
- 12:39Speaker 1: people might exhibit subclinical anxiety, which doesn't quite meet the
- 12:43Speaker 1: diagnostic criteria for SAD. How do we identify these individuals
- 12:48Speaker 1: and whether they might benefit from early intervention?
- 12:51Speaker 2: Great question. A study by researchers at Harvard uncovered that
- 12:55Speaker 2: those with subclinical anxiety are at higher risk for developing
- 12:59Speaker 2: SAD later on. Identifying and supporting these individuals through early
- 13:03Speaker 2: psychological interventions could be crucial. For example, mindfulness and cognitive
- 13:08Speaker 2: behavioral techniques can help manage these milder symptoms before they escalate.
- 13:13Speaker 1: Absolutely. And what about the therapeutic approaches? How effective are
- 13:18Speaker 1: they compared to each other? We hear a lot about
- 13:21Speaker 1: CBT and pharmacotherapy, but what about newer methods like virtual
- 13:25Speaker 1: reality exposure therapy?
- 13:27Speaker 2: That's wild when you look at the raw numbers. A
- 13:29Speaker 2: meta-analysis published in the Journal of Anxiety Disorders found that
- 13:33Speaker 2: CBT and exposure therapy were equally effective in reducing symptoms
- 13:37Speaker 2: of SAD. However, virtual reality therapy could offer a more
- 13:42Speaker 2: controlled and realistic simulation of social situations, potentially leading to
- 13:47Speaker 2: faster symptom reduction for some patients.
- 13:50Speaker 1: That's interesting, and it opens up the discussion about tailoring
- 13:53Speaker 1: treatment to individual needs. For instance, while CBT works wonders
- 13:58Speaker 1: for many, some people might not respond well to it.
- 14:02Speaker 1: In such cases, what would be the next step?
- 14:05Speaker 2: Good question. A multidisciplinary approach often works best. If pharmacotherapy
- 14:10Speaker 2: doesn't work or the patient doesn't respond to CBT, combining
- 14:14Speaker 2: these with alternative therapies like mindfulness and meditation can be
- 14:17Speaker 2: very effective. The key is finding the right mix to
- 14:21Speaker 2: suit each individual's specific needs.
- 14:23Speaker 1: Exactly. And we mustn't overlook the importance of patient adherence.
- 14:28Speaker 1: Consistency and the willingness to engage in these therapies are crucial.
- 14:33Speaker 1: It's a holistic journey that requires patience and support from
- 14:36Speaker 1: all stakeholders.
- 14:37Speaker 2: Agreed. It's a journey that requires patience and understanding from
- 14:41Speaker 2: everyone involved. The goal is to build resilience and coping
- 14:45Speaker 2: mechanisms that last beyond the treatment phase, ensuring long-term well-being.
- 14:50Speaker 1: As we look ahead, we are seeing a convergence of
- 14:52Speaker 1: technology and therapy in the treatment of SAD. For instance...
- 14:57Speaker 1: Virtual Reality Exposure Therapy, VRET, is gaining traction. How does
- 15:02Speaker 1: this work, exactly?
- 15:04Speaker 2: In VRET, patients are exposed to virtual social situations in
- 15:08Speaker 2: a safe, controlled environment that replicate real-life triggers for their anxiety.
- 15:13Speaker 2: It's like a simulation that allows them to practice facing
- 15:16Speaker 2: their fears in a low-pressure situation. The key is it
- 15:19Speaker 2: can be customized to match their specific triggers.
- 15:22Speaker 1: Right, and that's the crucial nuance here. Patients can gradually
- 15:27Speaker 1: build their confidence by facing these situations repeatedly and successfully.
- 15:32Speaker 1: It's not just about exposure, it's about controlled, iterative practice.
- 15:37Speaker 1: It's fascinating to see how VR can create a safe
- 15:40Speaker 1: space for therapy.
- 15:41Speaker 2: Absolutely. But let's not forget the potential for neurofeedback. This
- 15:45Speaker 2: approach is about training the brain to regulate its own responses,
- 15:49Speaker 2: specifically targeting the amygdala and its hyper-responsiveness in SADD. It's
- 15:54Speaker 2: like giving the brain a workout to manage its fear
- 15:56Speaker 2: responses more effectively.
- 15:57Speaker 1: That's wild when you look at the raw numbers. Some
- 16:00Speaker 1: studies show that combined therapy with vet and neurofeedback can
- 16:04Speaker 1: significantly reduce symptoms. But there are still unsolved questions. For example,
- 16:10Speaker 1: does neurofeedback actually change brain chemistry in a meaningful way,
- 16:14Speaker 1: or is it purely a placebo effect?
- 16:16Speaker 2: Great point. Exactly those are the contradictions we need to
- 16:19Speaker 2: probe further. If we can confirm that neurofeedback is causing real,
- 16:24Speaker 2: lasting changes, that would open up a whole new frontier
- 16:27Speaker 2: in SAD treatment. However, the technology isn't yet perfected, and
- 16:32Speaker 2: we need more longitudinal studies to understand long-term effects. True.
- 16:37Speaker 1: Moving beyond clinical environments, TRI is also the role of
- 16:41Speaker 1: digital therapeutics. Apps and wearable devices could offer more accessible,
- 16:46Speaker 1: on-demand support. But how do we ensure these tools are
- 16:50Speaker 1: not just fashionable tech, but are actually effective in managing SAD?
- 16:54Speaker 2: Exactly, which brings up an interesting contradiction. On the one hand,
- 16:59Speaker 2: technology can make therapy more accessible. On the other, to
- 17:03Speaker 2: raise the risk of over-reliance on apps that might lack
- 17:06Speaker 2: the personalized care from a therapist, striking that balance is key.
- 17:11Speaker 1: And that's why integrating different perspectives, psychological, technological, and patient-centered,
- 17:16Speaker 1: is so vital. Multidisciplinary approaches are where the real innovation lies.
- 17:22Speaker 1: By bringing together experts from various fields, we can create
- 17:26Speaker 1: more holistic treatment plans that address the full spectrum of SAD.
- 17:30Speaker 2: Agreed. It's a journey, but every step forward is a
- 17:34Speaker 2: step towards more effective and personalized treatment. The future is
- 17:38Speaker 2: bright with these advancements, but we have to be mindful
- 17:41Speaker 2: of the complexities and contradictions along the way.
- 17:44Speaker 1: That brings us to the end of today's episode. Thank
- 17:47Speaker 1: you so much for spending part of your day with me.
- 17:50Speaker 1: If you found this episode's tips helpful and want to
- 17:52Speaker 1: make sure you don't miss the next conversation, please take
- 17:55Speaker 1: a quick second to hit that subscribe or follow button
- 17:58Speaker 1: on whatever platform you are listening on. It's a completely
- 18:02Speaker 1: free way to support the show and helps more people
- 18:04Speaker 1: find us. This podcast is independently produced, so if you
- 18:08Speaker 1: are ever in a position where you would like to
- 18:10Speaker 1: help keep it running, we do accept small donations. You
- 18:14Speaker 1: can find a link right in the episode description below
- 18:17Speaker 1: to buy us a coffee or contribute what you can.
- 18:20Speaker 1: Every bit genuinely helps. Take care of yourself. Stay balanced.
- 18:25Speaker 1: And we will talk again soon.